Inositol
In clinical developmentAlso known as Amino-Cerv, Inositech, L-myo-Inositol, Pregnitude+4 more
Amino-Cerv, Inositech, L-myo-Inositol, Pregnitude, meso-Inositol, myo-inositol, 1,2,3,5/4,6-cyclohexanehexol, cis-1,2,3,5-trans-4,6-cyclohexanehexol.
Recent clinical, regulatory, research and industry developments relating to this drug.
Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder
The human milk component <i>myo</i>-inositol promotes neuronal connectivity.
A Double-Blind, Placebo-Controlled Study of Inositol in Trichotillomania
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- Proceedings of the National Academy of Sciences of the United States of America1
- Biederer T1
- Carbone BE1
- Chowdhury D1
- Hondmann D1
- Israel E1
- Kondratiuk I1
- Kuang C1
- Labhart B1
- Perinatal Institute1
- Tufts University School of Medicine1
- United States Department of Agriculture Human Nutrition Research Center on Aging1
- Yale School of Medicine1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials